Ovarian hyperstimulation syndrome: an endocrinopathy?

Area of Science:

• Reproductive endocrinology and medicine
• Molecular and cellular biology

Background:

• Ovarian hyperstimulation syndrome (OHSS) is a significant complication of controlled ovarian stimulation, with its exact pathogenesis not fully understood.
• Accumulating evidence points to the involvement of various cytokines, notably vascular endothelial growth factor (VEGF), in OHSS development.
• The complex interplay of multiple cytokines and endocrine factors is likely crucial in OHSS pathogenesis.

Purpose of the Study:

• To elucidate the complex pathogenesis of ovarian hyperstimulation syndrome (OHSS).
• To investigate the role of specific cytokines and endocrine factors in OHSS.
• To explore the potential for distinguishing clinical forms of OHSS for improved prediction and prevention.

Main Methods:

• Review of existing evidence on cytokine and endocrine factor involvement in OHSS.
• Analysis of recent studies linking specific cytokines to functional abnormalities in severe OHSS.
• Examination of clinical data to identify distinct forms of OHSS based on onset time.

Main Results:

• Evidence supports a role for cytokines, particularly vascular endothelial growth factor, in OHSS.
• OHSS pathogenesis appears to involve a complex network of interacting cytokines and endocrine factors.
• Specific cytokines correlate with distinct functional abnormalities observed in severe OHSS.

Conclusions:

• The pathogenesis of OHSS is complex, involving multiple interacting molecular and endocrine factors.
• Identifying specific cytokine roles and clinical presentations may improve OHSS prediction and prevention strategies.
• Distinguishing clinical forms of OHSS based on onset offers practical implications for patient management.